NKT Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety, Pharmacokinetic, and Pharmacodynamic Study of NKTT120 in Adult Patients With Stable Sickle Cell Disease (SCD) (NCT01783691) | NKT Therapeutics | 2013-02-01 |
Track NKT Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.